Guidance for industry Q3A impurities in new drug substances.
|Corporate Authors:||, ,|
|Format:||Government Document Online Conference Proceeding Book|
Silver Spring, MD : Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; Center for Biologics Evaluation and Research,
No Tags, Be the first to tag this record!